(SKWD) Skyward Specialty Insurance - Ratings and Ratios
General, Auto, Property, Workers, Liability
SKWD EPS (Earnings per Share)
SKWD Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 33.3% |
| Value at Risk 5%th | 53.1% |
| Relative Tail Risk | -2.85% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.02 |
| Alpha | -12.65 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.329 |
| Beta | 0.599 |
| Beta Downside | 0.569 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.95% |
| Mean DD | 7.44% |
| Median DD | 4.66% |
Description: SKWD Skyward Specialty Insurance November 11, 2025
Skyward Specialty Insurance Group, Inc. (NASDAQ: SKWD) is a Houston-based holding company that underwrites a broad suite of U.S. commercial property-and-casualty lines, including general and excess liability, professional liability, commercial auto, workers’ compensation, surety, agriculture, credit, and niche cannabis insurance. The firm, originally incorporated in 2006 as Houston International Insurance Group, rebranded to its current name in November 2020.
According to its most recent 10-K (FY 2023), Skyward reported net written premiums of roughly $420 million, a combined ratio of 93.5% (indicating underwriting profitability), and a return on equity (ROE) of about 12.8%-both above the industry median for specialty insurers. The balance sheet shows a leverage ratio of 1.6 ×, comfortably within regulatory limits, and an investment portfolio yielding ~4.2% after fees.
Key drivers for Skyward’s performance include: (1) the continued expansion of commercial construction and infrastructure spending in the United States, which fuels demand for property and liability coverage; (2) heightened climate-related loss exposure that pressures pricing and loss reserves across the P&C sector; and (3) the rapid growth of the legal cannabis market, where specialized insurance remains under-served and offers premium-earning opportunities.
For a deeper, data-rich analysis of SKWD’s valuation metrics and scenario modeling, you may find ValueRay’s platform a useful next step.
SKWD Stock Overview
| Market Cap in USD | 1,974m |
| Sub-Industry | Property & Casualty Insurance |
| IPO / Inception | 2023-01-13 |
| Return 12m vs S&P 500 | -16.8% |
| Analyst Rating | 3.83 of 5 |
SKWD Dividends
Currently no dividends paidSKWD Growth Ratios
| CAGR 3y | 51.62% |
| CAGR/Max DD Calmar Ratio | 1.67 |
| CAGR/Mean DD Pain Ratio | 6.94 |
| Current Volume | 192.9k |
| Average Volume | 301.1k |
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (141.2m TTM) > 0 and > 6% of Revenue (6% = 80.3m TTM) |
| FCFTA 0.08 (>2.0%) and ΔFCFTA -2.93pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 160.7% (prev 129.8%; Δ 30.86pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.00 (>3.0%) and CFO 21.9m <= Net Income 141.2m (YES >=105%, WARN >=100%) |
| Net Debt (-60.1m) to EBITDA (190.1m) ratio: -0.32 <= 3.0 (WARN <= 3.5) |
| Current Ratio 6.39 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (41.9m) change vs 12m ago 1.07% (target <= -2.0% for YES) |
| Gross Margin 28.12% (prev 46.88%; Δ -18.76pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 32.66% (prev 30.27%; Δ 2.39pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 24.36 (EBITDA TTM 190.1m / Interest Expense TTM 7.72m) >= 6 (WARN >= 3) |
Altman Z'' 3.60
| (A) 0.47 = (Total Current Assets 2.55b - Total Current Liabilities 398.9m) / Total Assets 4.59b |
| (B) 0.05 = Retained Earnings (Balance) 223.9m / Total Assets 4.59b |
| (C) 0.05 = EBIT TTM 188.1m / Avg Total Assets 4.10b |
| (D) 0.06 = Book Value of Equity 233.9m / Total Liabilities 3.63b |
| Total Rating: 3.60 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 81.40
| 1. Piotroski 3.0pt = -2.0 |
| 2. FCF Yield data missing |
| 3. FCF Margin 27.76% = 6.94 |
| 4. Debt/Equity 0.10 = 2.49 |
| 5. Debt/Ebitda -0.32 = 2.50 |
| 6. ROIC - WACC (= 6.42)% = 8.02 |
| 7. RoE 16.11% = 1.34 |
| 8. Rev. Trend 98.64% = 7.40 |
| 9. EPS Trend 94.01% = 4.70 |
What is the price of SKWD shares?
Over the past week, the price has changed by +1.82%, over one month by +8.22%, over three months by +1.67% and over the past year by -3.75%.
Is Skyward Specialty Insurance a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SKWD is around 53.48 USD . This means that SKWD is currently overvalued and has a potential downside of 9.82%.
Is SKWD a buy, sell or hold?
- Strong Buy: 3
- Buy: 4
- Hold: 5
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SKWD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 61.4 | 26.1% |
| Analysts Target Price | 61.4 | 26.1% |
| ValueRay Target Price | 59.3 | 21.8% |
SKWD Fundamental Data Overview November 17, 2025
P/E Trailing = 14.451
P/E Forward = 10.7066
P/S = 1.4781
P/B = 2.0509
P/EG = 0.7245
Beta = 0.559
Revenue TTM = 1.34b USD
EBIT TTM = 188.1m USD
EBITDA TTM = 190.1m USD
Long Term Debt = 76.6m USD (from longTermDebt, last quarter)
Short Term Debt = 100.0m USD (from shortTermDebt, last quarter)
Debt = 100.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -60.1m USD (from netDebt column, last quarter)
Enterprise Value = 108.5m USD (1.97b + Debt 100.0m - CCE 1.97b)
Interest Coverage Ratio = 24.36 (Ebit TTM 188.1m / Interest Expense TTM 7.72m)
FCF Yield = 342.4% (FCF TTM 371.4m / Enterprise Value 108.5m)
FCF Margin = 27.76% (FCF TTM 371.4m / Revenue TTM 1.34b)
Net Margin = 10.55% (Net Income TTM 141.2m / Revenue TTM 1.34b)
Gross Margin = 28.12% ((Revenue TTM 1.34b - Cost of Revenue TTM 961.7m) / Revenue TTM)
Gross Margin QoQ = 31.18% (prev 29.58%)
Tobins Q-Ratio = 0.02 (Enterprise Value 108.5m / Total Assets 4.59b)
Interest Expense / Debt = 1.92% (Interest Expense 1.92m / Debt 100.0m)
Taxrate = 24.19% (14.6m / 60.5m)
NOPAT = 142.6m (EBIT 188.1m * (1 - 24.19%))
Current Ratio = 6.39 (Total Current Assets 2.55b / Total Current Liabilities 398.9m)
Debt / Equity = 0.10 (Debt 100.0m / totalStockholderEquity, last quarter 961.4m)
Debt / EBITDA = -0.32 (Net Debt -60.1m / EBITDA 190.1m)
Debt / FCF = -0.16 (Net Debt -60.1m / FCF TTM 371.4m)
Total Stockholder Equity = 876.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.07% (Net Income 141.2m / Total Assets 4.59b)
RoE = 16.11% (Net Income TTM 141.2m / Total Stockholder Equity 876.5m)
RoCE = 19.73% (EBIT 188.1m / Capital Employed (Equity 876.5m + L.T.Debt 76.6m))
RoIC = 14.31% (NOPAT 142.6m / Invested Capital 996.1m)
WACC = 7.89% (E(1.97b)/V(2.07b) * Re(8.22%) + D(100.0m)/V(2.07b) * Rd(1.92%) * (1-Tc(0.24)))
Discount Rate = 8.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.85%
[DCF Debug] Terminal Value 80.87% ; FCFE base≈381.5m ; Y1≈470.6m ; Y5≈802.9m
Fair Price DCF = 326.0 (DCF Value 13.20b / Shares Outstanding 40.5m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 94.01 | EPS CAGR: 47.59% | SUE: 4.0 | # QB: 4
Revenue Correlation: 98.64 | Revenue CAGR: 29.19% | SUE: 4.0 | # QB: 1
Additional Sources for SKWD Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle